103
IRUS Total
Downloads
  Altmetric

Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection.

File Description SizeFormat 
eabf3698.full.pdfPublished version2.04 MBAdobe PDFView/Open
Title: Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection.
Authors: Reynolds, CJ
Swadling, L
Gibbons, JM
Pade, C
Jensen, MP
Diniz, MO
Schmidt, NM
Butler, DK
Amin, OE
Bailey, SNL
Murray, SM
Pieper, FP
Taylor, S
Jones, J
Jones, M
Lee, W-YJ
Rosenheim, J
Chandran, A
Joy, G
Di Genova, C
Temperton, N
Lambourne, J
Cutino-Moguel, T
Andiapen, M
Fontana, M
Smit, A
Semper, A
O'Brien, B
Chain, B
Brooks, T
Manisty, C
Treibel, T
Moon, JC
COVIDsortium investigators
Noursadeghi, M
COVIDsortium immune correlates network
Altmann, DM
Maini, MK
McKnight, Á
Boyton, RJ
Item Type: Journal Article
Abstract: Understanding the nature of immunity following mild/asymptomatic infection with SARS-CoV-2 is crucial to controlling the pandemic. We analyzed T cell and neutralizing antibody responses in 136 healthcare workers (HCW) 16-18 weeks after United Kingdom lockdown, 76 of whom had mild/asymptomatic SARS-CoV-2 infection captured by serial sampling. Neutralizing antibodies (nAb) were present in 89% of previously infected HCW. T cell responses tended to be lower following asymptomatic infection than in those reporting case-definition symptoms of COVID-19, while nAb titers were maintained irrespective of symptoms. T cell and antibody responses were sometimes discordant. Eleven percent lacked nAb and had undetectable T cell responses to spike protein but had T cells reactive with other SARS-CoV-2 antigens. Our findings suggest that the majority of individuals with mild or asymptomatic SARS-CoV-2 infection carry nAb complemented by multispecific T cell responses at 16-18 weeks after mild or asymptomatic SARS-CoV-2 infection.
Issue Date: 23-Dec-2020
Date of Acceptance: 18-Dec-2020
URI: http://hdl.handle.net/10044/1/86000
DOI: 10.1126/sciimmunol.abf3698
ISSN: 2470-9468
Publisher: American Association for the Advancement of Science
Start Page: 1
End Page: 19
Journal / Book Title: Science Immunology
Volume: 5
Issue: 54
Copyright Statement: © 2020, American Association for the Advancement of Science https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: Antibodies, Neutralizing
Antibodies, Viral
Asymptomatic Infections
COVID-19
Case-Control Studies
Cross-Sectional Studies
Humans
SARS-CoV-2
T-Lymphocytes
Antibodies, Neutralizing
Antibodies, Viral
Asymptomatic Infections
COVID-19
Case-Control Studies
Cross-Sectional Studies
Humans
SARS-CoV-2
T-Lymphocytes
COVIDsortium investigators
COVIDsortium immune correlates network
T-Lymphocytes
Humans
Antibodies, Viral
Case-Control Studies
Cross-Sectional Studies
Antibodies, Neutralizing
Asymptomatic Infections
COVID-19
SARS-CoV-2
Publication Status: Published
Conference Place: United States
Online Publication Date: 2020-12-23
Appears in Collections:Department of Immunology and Inflammation
Department of Infectious Diseases
Imperial College London COVID-19



This item is licensed under a Creative Commons License Creative Commons